首页 | 本学科首页   官方微博 | 高级检索  
检索        

腺病毒介导MDA-7/IL-24选择性杀伤肝癌 细胞HepG2的研究
引用本文:王从俊,薛新波,易继林,陈堃,郑建伟,曾建平,许荣华,王炜煜,吴在德.腺病毒介导MDA-7/IL-24选择性杀伤肝癌 细胞HepG2的研究[J].中国普通外科杂志,2006,15(11):13-854.
作者姓名:王从俊  薛新波  易继林  陈堃  郑建伟  曾建平  许荣华  王炜煜  吴在德
作者单位:华中科技大学同济医学院附属同济医院胆胰外科中心,湖北,武汉,430030
基金项目:湖北省科技厅科技攻关项目
摘    要:目的 :观察MDA-7/IL-24基因对肝癌的选择性杀伤作用,为肝癌的基因治疗提供理论基础。 方法 :将携带人MDA-7/IL-24基因的腺病毒Ad.mda-7感染人正常肝细胞L02和肝癌细胞HepG2;用RT-PCR法观察MDA-7/IL-24基因的表达;ELISA方法检测细胞培养上清液中MDA-7/IL-24蛋白的浓度;4甲基偶氮唑蓝染色法(MTT)及Hoechst染色观察MDA-7/IL-24对肝癌细胞的生长抑制和杀伤作用;Annexin-V和PI双染后流式细胞仪检测2种细胞的凋亡;用流式细胞仪检测细胞周期。 结果 :复制缺陷型腺病毒能介导外源基因MDA-7/IL-24在肝癌细胞株HepG2和正常细胞L02中的高效表达;细胞培养上清液中有MDA-7/IL-24蛋白的表达; MDA-7/IL-24能明显抑制肝癌细胞生长并可促进肝癌细胞的凋亡;MDA-7/IL-24阻滞肝癌细胞于G2/M期,能选择性杀伤肝癌细胞而对正常的肝细胞无阻滞作用和毒性作用。结论 :复制缺陷型重组腺病毒载体Ad.mda-7能介导MDA-7/IL-24基因在人肝癌细胞中高效表达,促使细胞增殖阻滞及诱导肿瘤细胞凋亡,选择性地杀伤肝癌细胞HepG2,而对正常肝细胞L02无任何毒性作用。

关 键 词:肝肿瘤  实验性/治疗  基因疗法  肝癌细胞HepG2  基因MDA-7/IL-24
文章编号:1005-6947(2006)11-0849-06
收稿时间:2005-09-21
修稿时间:2005-12-05

Adenovirus mediated MDA-7/IL-24 gene transfer selectively killshepatocellular carcinoma lines HepG2
WANG Cong-jun,XU Xin-bo,YI Ji-lin,CHEN Kun,ZHEN Jian-wei,ZENG Jian-ping,XU Rong-hu,WANG Wei-yu,WU Zai-de.Adenovirus mediated MDA-7/IL-24 gene transfer selectively killshepatocellular carcinoma lines HepG2[J].Chinese Journal of General Surgery,2006,15(11):13-854.
Authors:WANG Cong-jun  XU Xin-bo  YI Ji-lin  CHEN Kun  ZHEN Jian-wei  ZENG Jian-ping  XU Rong-hu  WANG Wei-yu  WU Zai-de
Institution:Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongfi Medical College, Huazhong University of Science and Technology, Wuhan 430030 , China
Abstract:Objective To investigate the selective killing effect of MDA/IL-24 on human hepatocellular carcinoma line HepG2 in vitro and provide a theoretical basis for gcne therapy of hepatocellular carcinoma. Methods The MDA-7/IL-24 gene was transfected into human hepatocullulat carcinoma cell line HepG2 and normal liver cell llne L02 with a replication-incompetent adenovirus vector. The mRNA and protein expression of MDA7/IL-24 in HepG2 and L02 cells was examined by RT-PCR and ELISA assay respectively. MTT assay and flow cytometry were used to study tumor cell proliferation and cell cycle in vitro. Hoechst and Annexin-V and PI staining were studied to indicate the apoptosis. Results RT-PCR confirmed that the exogenous MDA-7/IL-24 gene was expressed in HepG2 and L02 cells. The protein product was confirmed by assay of the supernatant with ELISA. MTT and apoptosis test indicated MDA-7/IL-24 induced growth suppression and cell apoptosis of the HepG2 cell in vitro but not in cell line L02 , and cell cycle test revealed MDA-7/IL-24 could block HepG2 cell in G2/M hut not in L02. Conclusions MDA-7/IL-24 selectively induces growth suppression and apoptosis in lines HepG2 in vitro but not in L02 cell, which indicates that adenovirus mediated MDA-7/IL-24 can be an excellent tool for gene therapy in hepatocellular carcinoma.
Keywords:Liver Neoplasms  Experimental/tiler  Gene therapy  Hepatocellalar Carcinoma HepG2  Gene  MDA- 7/IL-24
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号